ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

ARTL Artelo Biosciences Inc

1,25
-0,075 (-5,66%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Artelo Biosciences Inc ARTL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,075 -5,66% 1,25 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,26 1,25 1,30 1,25 1,325
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
04/6/202414:30GLOBEArtelo Biosciences Presents Important New Data on ART26.12..
29/5/202414:30GLOBEArtelo Biosciences Presents Highly Encouraging Data Towards..
13/5/202414:00GLOBEArtelo Biosciences Reports First Quarter 2024 Financial..
10/5/202415:00GLOBEArtelo Biosciences to Present at the Pharma Partnering..
23/4/202414:30GLOBEArtelo Biosciences Announces Publication of Peer-Reviewed..
22/4/202414:30GLOBEArtelo Biosciences CEO to Appear on Benzinga All Access on..
25/3/202413:00GLOBEArtelo Biosciences Reports Fiscal 2023 Year-End Financial..
12/3/202414:15GLOBEArtelo Biosciences Selected as a Finalist in Johnson &..
23/1/202414:30GLOBEArtelo Biosciences Announces Publication of New..
08/1/202414:30GLOBEArtelo Biosciences Announces Selection of Worldwide Clinical..
05/12/202314:30GLOBEArtelo Biosciences Presents New Preclinical Data on ART12.11..
30/11/202315:00GLOBEArtelo Biosciences to Present Important New Preclinical Data..
13/11/202314:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202314:00GLOBEArtelo Biosciences Reports Third Quarter 2023 Financial..
09/11/202315:00GLOBEArtelo Biosciences Announces Publication of New..
02/11/202313:30GLOBEArtelo Biosciences to Present Preclinical Data Showcasing..
04/10/202314:30GLOBEPrincipal Investigator of Artelo’s CAReS Trial to..
13/9/202314:30GLOBEArtelo Biosciences to Present at the 13th Congress of the..
07/9/202314:00GLOBEArtelo Biosciences Completes Positive Pre-IND Meeting with..
06/9/202315:00GLOBEArtelo Biosciences to Present at the 6th Cannabinoid-Derived..
05/9/202315:00GLOBEArtelo Biosciences to Present at the H.C. Wainwright 25th..
10/8/202314:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:00GLOBEArtelo Biosciences Reports Second Quarter 2023 Financial..
08/8/202322:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/8/202322:34EDGAR2Form 8-K - Current report
19/7/202315:00GLOBEArtelo Biosciences to Present New Mechanism of Action Data..
17/7/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
10/7/202314:30GLOBEArtelo Biosciences CEO to Participate in the Benzinga All..
07/7/202314:23EDGAR2Form DEL AM - Delaying amendment
06/7/202322:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03/7/202320:15EDGAR2Form 8-K - Current report
03/7/202320:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/6/202314:30GLOBEArtelo Biosciences Announces Sponsorship of The William A...
27/6/202314:30GLOBEArtelo Biosciences Announces Important New Data on ART26.12..
26/6/202314:30GLOBEArtelo Biosciences Reports Superior Preclinical..